ArticleOncology letters2026

An m6A-programmed cell death signature predicts prognosis and identifies STK25 as a therapeutic target in colon adenocarcinoma.

Hezhi Yu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.